Biolife solutions to report first quarter 2025 financial results and business update on may 8, 2025

Bothell, wash. , april 30, 2025 /prnewswire/ -- biolife solutions, inc. (nasdaq: blfs), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("cgt") market, today announced the company's first quarter 2025 financial results will be released after market close on thursday, may 8, 2025.

BLFS Ratings Summary

BLFS Quant Ranking